Login to Your Account



Basilea: Ceftobriprole Custody in Post-EMA Divorce from J&J

By Cormac Sheridan


Monday, February 22, 2010
A ray of light appeared Friday to pierce the gloom surrounding Basilea Pharmaceutica AG's program for its cephalosporin antibiotic ceftobiprole (Zevtera), which is in development for complicated skin and soft tissue infections. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription